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Peeling skin syndrome (PSS) is a group
of recessive skin fragility genoderma-
toses with superficial peeling of the skin
as the characteristic clinical feature that
may be accompanied by ichthyosis
and/or inflammation. Localized PSS is
caused by mutations in TGM5 and
CSTA (Blaydon et al., 2011; Cassidy
et al., 2005), whereas generalized PSS
is caused by mutations in CDSN (Oji
et al., 2010), SERPINB8 (Pigors et al.,
2016) and CHST8 (Cabral et al.,
2012). Recently, in a family with
generalized ichthyotic PSS, a homozy-
gous nonsense mutation in FLG2 was
found, thereby broadening the PSS ge-
netic spectrum (Alfares et al., 2017).
Here, we present two siblings with
generalized peeling skin and ichthyosis
with the same homozygous FLG2
nonsense mutation and provide clues to
the pathogenesis of the epidermal sep-
aration and abnormal cornification.
The index patient is an 11-year-old
girl from consanguineous Moroccan
parents (V:5) (Figure 1). At birth, she was
erythrodermic, and afterward, dry skin
was present with superficial peeling of
the skin upon minor trauma, leaving a
red denuded area. The lesions healed
with hyperpigmentation without leaving
scars. Warm and humid environment
aggravated the peeling tendency. Over
the knees and elbows, hyperkeratosis
and ichthyosis were present. Hairs,
nails, and mucosae were unaffected.
The condition markedly improved dur-
ing childhood. One older brother (V:4)
was similarly affected and also had
remarkable improvement with age.
The index patient was first analyzed
with our targeted next-generation
sequencing gene panel for skin fragility
disorders, which includes CSTA, CDSN,Abbreviations: PSS, peeling skin syndrome; SC, stratu
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online). Because no pathogenic or likely
pathogenic variants were identified that
could explain the phenotype, whole-
exome sequencing followed by
comprehensive gene network analysis
was performed next, using the known
PSS genes as bait (see Supplementary
Materials). This uncovered a homozy-
gous nonsense mutation in exon 3 of the
FLG2 gene (c.632C>G,p.(Ser211*),
NM_001014342.2), encoding filaggrin
2. This variant was not yet described as a
disease-causing mutation at that time,
was identified only three times in
245,962 exomes and 30,956 genomes
(Exome Aggregation Consortium), and
was not reported in the dbSNP or
ClinVar databases (http://gnomad.
broadinstitute.org/variant/1-152329630-
G-C). Sanger sequencing confirmed the
homozygous mutation in the index pa-
tient (V:5) and her affected brother (V:4).
Both unaffected parents were heterozy-
gous carriers, and four other unaffected
siblings were either heterozygous car-
riers or homozygous wild type, indi-
cating co-segregation of the mutation
with the phenotype. Altogether, these
data strongly supported the FLG2
p.(Ser211*) variant being the disease-
causing mutation in this family.
Histopathology of perilesional skin
(V:5) showed separation in the lower
stratum corneum (SC) with parakeratosis
(Figure 1g). Electron microscopy showed
abnormal keratin bundles and kerato-
hyalin granules in the stratum gran-
ulosum (SG). Corneocytes were swollen,
interdigitating, and loosely packed and
contained light grey globular inclusions
with central abnormal vesicles (see
Supplementary Materials).
Immunofluorescence microscopy
(see Supplementary Table S1 online) ofm corneum; SG, stratum granulosum
; corrected proof published online 19 April 2018
ehalf of the Society for Investigative Dermatology.perilesional skin showed absent stain-
ing with antibody Ab122001 (anti-
filaggrin-2 residues 280e381), whereas
SG and SC in control skin stained
positively (Figure 2). Staining with
antibodies Abx100795 and
Mbs20059595 against the C-terminal
part of filaggrin-2 showed a faint posi-
tive staining (see Supplementary
Figure S2 online). Keratin 2 and cor-
neodesmosin stainings were reduced in
patient skin. The latter staining indi-
cated swollen corneocytes (Figure 2,
arrowhead). Desmocollin-1 and
desmoglein-1 expression were reduced
in SG, and desmoglein-1 staining was
retained in the SC in perilesional skin at
age 4 years, but all these staining results
were normal at age 10 years (Figure 2).
Loricrin and filaggrin-1 stainings were
absent in perilesional skin at age 4
years but were near normal at age 10
years. Staining results for keratin 10,
claudin-1, and desmoplakin were
normal (see Supplementary Figure S3
online).
Our results show that that biallelic
FLG2 nonsense mutations are associ-
ated with generalized ichthyotic PSS
with a level of separation in the lower
SC and that, in conjunction with
in vitro observations by Pendaries et al.
(2015), filaggrin-2 is essential for proper
cornification and integrity of the SC.
Filaggrin-2, like filaggrin-1, belongs
to the S100 fused-type protein family
(Wu et al., 2009). The 248-kDa pre-
cursor protein, produced by granular
keratinocytes, consists of an N-termi-
nal S100 domain/EF hand domain,
which is a putative calcium binding
site, followed by A- and B-repeat
domains separated by a spacer. The
gene consists of two small exons
followed by a large third exon encod-
ing the filaggrin repeats (see
Supplementary Figure S4 online). The
repeats are thought to be proteolyti-
cally cleaved into smaller subunits,
like filaggrin-1, and deposited in thewww.jidonline.org 1881
Figure 1. Clinical features of the index patient. (a) The patient at age 4 years showing the back with
superficial peeling (insert), crusts and hyperpigmented maculae. (bee) The patient at age 10 years
showing (b) marked improvement, (c) mild hyperkeratosis on the knees with mild ichthyosis,
(d) periungual peeling, and (e) mild plantar hyperkeratosis on pressure points. (f) Pedigree of the family
described. Index patient is indicated by arrowhead. Squares indicate males, circles indicate females,
blackened symbols indicate affected individuals, and symbols with black dots indicate carriers
of the FLG2 mutation. FLG2 carrier status is indicated below each individual: e/e, homozygous wild
type; þ/e, heterozygous carrier; þ/þ, homozygous carrier. (g) Histopathology of a perilesional skin
biopsy sample of the index patient showed skin separation in the lower stratum corneum with
parakeratosis. Scale bar ¼ 50 mm.
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largely unknown, but because of its
similarity with filaggrin-1, it was
thought to play a role in epidermal
barrier function. Recently, filaggrin-2
was shown to be down-regulated in
atopic dermatitis skin (Trzeciak et al.,
2017), and heterozygous FLG2
nonsense mutations were associated
with more persistent atopic dermatitis
in African Americans (Margolis et al.,
2014). Neither heterozygosity nor ho-
mozygosity for the FLG2 mutation
was associated with atopy in our
family or the family described by
Alfares et al. (2017), although dry skin
was noted in carriers. A filaggrin-2
knockdown skin model (Pendaries
et al., 2015) showed parakeratosis,
down-regulation of loricrin, and
abnormal vesicles in the SC, all of
which we also observed in our patient
(see Supplementary Figures S1
and S2).
Processed filaggrin monomers are
known to be responsible for proper ker-
atin filament bundling (Lonsdale-Eccles
et al., 1982). Keratin 2 was reduced in
our patient. Filaggrin-2 possibly renders
corneocytes vulnerable because of inad-
equate keratin compaction during the
early phase of cornification (see
Supplementary Figure S1). An interaction
between filaggrin-2 and the desmo-
somal proteins desmocollin-2 and/or
desmoglein-2 has not been reported
before. However, using the Functional
Human Gene Network (Franke et al.,
2006), FLG2 gene expression was
found to be co-regulated with the
gene expression of DSC1 and DSG1
(http://molgenis27.target.rug.nl/gene/
ENSG00000143520). The reduction
in and altered distribution of
corneodesmosin, desmocollin-1, and
desmoglein-1, together with the clinical
data, indicate that filaggrin-2 is also
necessary for proper cell-cell adhesion in
the lower SC. The exact biochemical
mechanisms of these findings remain
elusive, as well as an explanation for
the remarkable improvement of the
phenotype during childhood.
In conclusion, evidence is accumu-
lating that loss of filaggrin-2 due to
biallelic mutations in FLG2 is associ-
ated with a generalized ichthyotic form
of PSS. Our data indicate that filaggrin-
2 is important for proper integrity and
mechanical strength of the SC.
Figure 2. Immunofluorescence microscopy of patient skin. Filaggrin-2 was absent in patient skin when stained with N-terminal antibody Ab122001
(directed against amino acids 280e381), slightly C-terminal of the mutation (amino acid 211). Corneodesmosin was absent at age 4 years and reduced at age
10 years. Note the thicker corneocytes (arrowheads), also observed in electron microscopy (see Supplementary Figure S1 online). Desmoglein-1 was
reduced and retained in the SC (arrowheads) at age 4 years, but results were normal at age 10 years. Keratin 2 staining was strongly reduced and visible in the
SC only at age 4 years and was overall reduced at age 10 years. Scale bars ¼ 50 mm.
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Figure 1. Association of vitiligo with nucleotide poly
locus 8q24.21. Results from the previous GWAS (Jin
dots) in the PVT1 region of chromosome locus 8q24.2
Haenszel meta-analysis combining data from GWAS1
against GRCh38/hg38 positions on chromosome 8 in
rs10087240 and rs4733823 are indicated. A genomic
orientations. GWAS, genome-wide association study;
S, genome-wide association study; SNP, single-
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morphisms in the PVT1 region of chromosome
et al., 2016) showing polymorphisms (black
1. elog10(P-values) derived from Cochran-Mantel-
, GWAS2, and GWAS3 are plotted
mega base pairs. Single-nucleotide polymorphisms
map is shown; arrows denote transcriptional
Mb, mega base pair; MIR, microRNA.TO THE EDITOR
Vitiligo is a common skin disease in
which depigmented patches of skin and
overlying hair result from autoimmune
destruction of melanocytes in the
involved regions, with elevated fre-
quencies of several other autoimmune
diseases (Picardo and Taı¨eb, 2018). We
previously carried out three genome-
wide association studies (GWASs) of
vitiligo in subjects of European-derived
white ethnic origin (EUR) and thereby
identified and confirmed 48 genetic
loci that are significantly associated
with vitiligo (Jin et al., 2010a, 2010b,
2012, 2016). Most of these loci harbor
genes that are involved in regulation of
immune cells, apoptosis, and melano-
cyte function (Spritz and Andersen,
2017). In addition to these loci, in our
previous GWAS we detected provi-
sional association of vitiligo with
another locus, PVT1. However, for
technical reasons this association could
not be verified by independent repli-
cation (Jin et al., 2016). Here, we report
the results of a genetic association study
of PVT1 in an independent set of EUR
vitiligo patients and control individuals.
We detected highly significant associ-
ation of PVT1 with vitiligo, both in this
replication study and in a meta-analysis
that combines the data from the repli-
cation study with the previous GWAS
data. These findings establish PVT1 as
a vitiligo susceptibility locus.The three GWASs of vitiligo in EUR
subjects have been described previ-
ously (GWAS1, GWAS2, GWAS3; Jin
et al., 2010a, 2012, 2016). Briefly,
subjects included 2,853 unrelated EUR
vitiligo patients and data from 37,405
unrelated EUR control individuals ob-
tained from the Database of Genotypes
and Phenotypes. Meta-analysis of data
from the three GWASs (Jin et al., 2016)identified apparent association of viti-
ligo with two single-nucleotide poly-
morphisms (SNPs) located within the
PVT1 gene at chromosome locus
8q24.21 (Figure 1), rs10087240 and
rs4733823, both surpassing the stan-
dard P-value less than 5.0  10e8 cri-
terion for genome-wide significance
(rs10087240: P ¼ 7.74  10e9, odds
ratio ¼ 1.18; rs4733823: P ¼ 3.04 
10e8, odds ratio ¼ 1.17). Association of
vitiligo with both SNPs was supported
by GWAS1 and GWAS3, but not by
GWAS2 (Table 1), likely because of the
low odds ratio and small sample size in
GWAS2. As shown in Table 1,
